<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01682694</url>
  </required_header>
  <id_info>
    <org_study_id>7798</org_study_id>
    <nct_id>NCT01682694</nct_id>
  </id_info>
  <brief_title>Glucosamine and Chondroitin Effects</brief_title>
  <acronym>GLANCE</acronym>
  <official_title>Glucosamine and Chondroitin Effects</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fred Hutchinson Cancer Research Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fred Hutchinson Cancer Research Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A common starting dose of glucosamine and chondroitin will reduce inflammation as reflected
      by a reduction in serum C-reactive protein.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Use of glucosamine and chondroitin have been associated with reduced cancer and overall
      mortality. The aim of this study is to determine whether a common starting dose of
      glucosamine and chondroitin (1500 mg/d + 1200 mg/d, respectively) reduces systemic
      inflammation as reflected by a reduction in high sensitivity C-reactive protein.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2012</start_date>
  <completion_date type="Actual">August 2013</completion_date>
  <primary_completion_date type="Actual">August 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>hsCRP</measure>
    <time_frame>1 year</time_frame>
    <description>hsCRP is a biomarker of systemic inflammation</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>untargeted (exploratory) serum metabolomics (differences in small molecule abundance ratios)</measure>
    <time_frame>1 year</time_frame>
    <description>The mechanisms of action of glucosamine and chondroitin are currently unknown. Untargeted metabolomic assays of serum will be undertaken for exploratory analyses of potential effects of glucosamine and chondroitin. Significant differences in abundance ratios of small molecules between the intervention and placebo will be reported.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Inflammation</condition>
  <arm_group>
    <arm_group_label>Glucosamine and Chondroitin</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Glucosamine and Chondroitin</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Inactive ingredients</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Glucosamine and Chondroitin</intervention_name>
    <description>Glucosamine (1500 mg) and Chondroitin (1200 mg)</description>
    <arm_group_label>Glucosamine and Chondroitin</arm_group_label>
    <other_name>Nutramax</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>placebo</intervention_name>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy

          -  Overweight (body mass index kg/m2 (BMI) between 25 and 32.5)

          -  Non-smoking men and women

          -  Aged 20-55y

        Exclusion Criteria:

          -  Chronic medical illness, history of gastrointestinal, hepatic, or renal disorders, or
             inflammatory conditions (including autoimmune and inflammatory diseases)

          -  Pregnancy or lactation

          -  Currently on a weight-loss diet

          -  BMI (body mass index) &lt; 25 or &gt; 30

          -  Alcohol intake of greater than 2 drinks/day

          -  Current use of prescription or over-the-counter medications, (Excluding oral
             contraceptives and hormone-secreting IUDs), including use of aspirin or NSAIDs more
             than 2 days per week

          -  Abnormal renal, liver or metabolic test

          -  Inability to swallow pills

          -  Known allergy to shellfish

          -  Not willing to take pills made from shellfish or animal sources

          -  Intention to relocate out of study area within next 4 months
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Fred Hutchinson Cancer Research Center</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98109</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 4, 2012</study_first_submitted>
  <study_first_submitted_qc>September 10, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 11, 2012</study_first_posted>
  <last_update_submitted>May 23, 2014</last_update_submitted>
  <last_update_submitted_qc>May 23, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 28, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Inflammation</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

